Live Quote · AMEXNBYHealthcare· Biotechnology

NovaBay Pharmaceuticals, Inc.

$1.47▼ 24.62%($-0.48)
MKT CAP $39.14MLAST EARNINGS Apr 1, 2026
50%
Bullish
TickerSpark Score
65/100
▌ Solid
97
Valuation
100
Profitability
10
Growth
88
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NBY research report →

Analyst RatingHold
2 Buy3 Hold0 Sell

Price Chart

-33.10% · this period
$95.80$48.48$1.16Apr 03Oct 03Apr 06
52-Week Range0% of range
Low
$1.11
Current
$1.47
High
$99.75